Multiple Myeloma Clinical Trials

The BLISS study population consists of participants enrolled in University of Leeds Clinical Trials Research Unit multiple myeloma trials from 2008 to 2021. Trial data extracted into BLISS will include demographics, treatment details, response assessments, progression outcomes, survival outcomes, and adverse events.